doi: 10.1161/01.RES.0000126921.29919.51
© 2004 American Heart Association, Inc.
Reviews |
Proteoglycans in Atherosclerosis and Restenosis
Key Roles for Versican
From the Department of Vascular Biology (T.N.W.), The Hope Heart Institute, Seattle, Wash; and Department of Anatomy with Radiology (M.J.M.), School of Medical Sciences, The University of Auckland, Auckland, New Zealand.
Correspondence to Thomas N. Wight, Department of Vascular Biology, The Hope Heart Institute, 1124 Columbia St, No. 783, Seattle, WA 98104-2046. E-mail twight{at}hopeheart.org
The proteoglycan versican is one of several extracellular matrix (ECM) molecules that accumulate in lesions of atherosclerosis and restenosis. Its unique structural features create a highly interactive molecule that binds growth factors, enzymes, lipoproteins, and a variety of other ECM components to influence fundamental events involved in vascular disease. Versican is one of the principal genes that is upregulated after vascular injury and is a prominent component in stented and nonstented restenotic lesions. The synthesis of versican is highly regulated by specific growth factors and cytokines and the principal source of versican is the smooth muscle cell. Versican interacts with hyaluronan, a long chain glycosaminoglycan, to create expanded viscoelastic pericellular matrices that are required for arterial smooth muscle cell (ASMC) proliferation and migration. Versican is also prominent in advanced lesions of atherosclerosis, at the borders of lipid-filled necrotic cores as well as at the plaque-thrombus interface, suggesting roles in lipid accumulation, inflammation, and thrombosis. Versican influences the assembly of ECM and controls elastic fiber fibrillogenesis, which is of fundamental importance in ECM remodeling during vascular disease. Collectively, these studies highlight the critical importance of this specific ECM component in atherosclerosis and restenosis.
Key Words: proteoglycans • versican • extracellular matrix • atherosclerosis • smooth muscle cells
This article has been cited by other articles:
 |
|
 |
|
  K. Tran-Lundmark, P.-K. Tran, G. Paulsson-Berne, V. Friden, R. Soininen, K. Tryggvason, T. N. Wight, M. G. Kinsella, J. Boren, and U. Hedin Heparan Sulfate in Perlecan Promotes Mouse Atherosclerosis: Roles in Lipid Permeability, Lipid Retention, and Smooth Muscle Cell Proliferation Circ. Res., July 3, 2008; 103(1): 43 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhao, E. Lee, A. M. Zukas, M. K. Middleton, M. Kinder, P. S. Acharya, J. A. Hall, D. J. Rader, and E. Pure CD44 Expressed on Both Bone Marrow-Derived and Non-Bone Marrow-Derived Cells Promotes Atherogenesis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1283 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Sabatine, L. Ploughman, K. L. Simonsen, O. A. Iakoubova, T. G. Kirchgessner, K. Ranade, Z. Tsuchihashi, K. E. Zerba, D. U. Long, C. H. Tong, et al. Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 562 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Read, M. Rahmani, S. Boroomand, S. Allahverdian, B. M. McManus, and P. S. Rennie Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter J. Biol. Chem., November 2, 2007; 282(44): 31954 - 31963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Kuznetsova, P. Issa, E. M. Perruccio, B. Zeng, J. M. Sipes, Y. Ward, N. T. Seyfried, H. L. Fielder, A. J. Day, T. N. Wight, et al. Versican-thrombospondin-1 binding in vitro and colocalization in microfibrils induced by inflammation on vascular smooth muscle cells J. Cell Sci., November 1, 2006; 119(21): 4499 - 4509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Goueffic, C. Guilluy, P. Guerin, P. Patra, P. Pacaud, and G. Loirand Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation Cardiovasc Res, November 1, 2006; 72(2): 339 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Isenberg, D. A. Wink, and D. D. Roberts Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses Cardiovasc Res, September 1, 2006; 71(4): 785 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Barre, N. Venkatesan, J. Magdalou, P. Netter, S. Fournel-Gigleux, and M. Ouzzine Evidence of calcium-dependent pathway in the regulation of human {beta}1,3-glucuronosyltransferase-1 (GlcAT-I) gene expression: a key enzyme in proteoglycan synthesis FASEB J, August 1, 2006; 20(10): 1692 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhuo, A. Kanamori, R. Kannagi, N. Itano, J. Wu, M. Hamaguchi, N. Ishiguro, and K. Kimata SHAP Potentiates the CD44-mediated Leukocyte Adhesion to the Hyaluronan Substratum J. Biol. Chem., July 21, 2006; 281(29): 20303 - 20314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Wiest, S. Hyrenbach, P. Bambul, B. Erker, A. Pezzini, I. Hausser, M.-L. Arnold, J. J. Martin, S. Engelter, P. Lyrer, et al. Genetic Analysis of Familial Connective Tissue Alterations Associated With Cervical Artery Dissections Suggests Locus Heterogeneity Stroke, July 1, 2006; 37(7): 1697 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-S. Zheng, M. Reis, C. Sparling, D. Y. Lee, D. P. La Pierre, C.-K. A. Wong, Z. Deng, S. Kahai, J. Wen, and B. B. Yang Versican G3 Domain Promotes Blood Coagulation through Suppressing the Activity of Tissue Factor Pathway Inhibitor-1 J. Biol. Chem., March 24, 2006; 281(12): 8175 - 8182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Huang, M. J. Merrilees, K. Braun, B. Beaumont, J. Lemire, A. W. Clowes, A. Hinek, and T. N. Wight Inhibition of Versican Synthesis by Antisense Alters Smooth Muscle Cell Phenotype and Induces Elastic Fiber Formation In Vitro and in Neointima After Vessel Injury Circ. Res., February 17, 2006; 98(3): 370 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van den Boom, M. Sarbia, K. von Wnuck Lipinski, P. Mann, J. Meyer-Kirchrath, B.H. Rauch, K. Grabitz, B. Levkau, K. Schror, and J.W. Fischer Differential Regulation of Hyaluronic Acid Synthase Isoforms in Human Saphenous Vein Smooth Muscle Cells: Possible Implications for Vein Graft Stenosis Circ. Res., January 6, 2006; 98(1): 36 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rodriguez-Lee, G. Ostergren-Lunden, B. Wallin, J. Moses, G. Bondjers, and G. Camejo Fatty Acids Cause Alterations of Human Arterial Smooth Muscle Cell Proteoglycans That Increase the Affinity for Low-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 130 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bathe, G. C. Rutledge, A. J. Grodzinsky, and B. Tidor Osmotic Pressure of Aqueous Chondroitin Sulfate Solution: A Molecular Modeling Investigation Biophys. J., October 1, 2005; 89(4): 2357 - 2371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kaplan-Albuquerque, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff Depletion of Serum Response Factor by RNA Interference Mimics the Mitogenic Effects of Platelet Derived Growth Factor-BB in Vascular Smooth Muscle Cells Circ. Res., September 2, 2005; 97(5): 427 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Talusan, S. Bedri, S. Yang, T. Kattapuram, N. Silva, P. J. Roughley, and J. R. Stone Analysis of Intimal Proteoglycans in Atherosclerosis-prone and Atherosclerosis-resistant Human Arteries by Mass Spectrometry Mol. Cell. Proteomics, September 1, 2005; 4(9): 1350 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tian, K. Ishibashi, K. Ishibashi, K. Reiser, R. Grebe, S. Biswal, P. Gehlbach, and J. T. Handa Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: A comprehensive transcriptional response PNAS, August 16, 2005; 102(33): 11846 - 11851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bathe, G. C. Rutledge, A. J. Grodzinsky, and B. Tidor A Coarse-Grained Molecular Model for Glycosaminoglycans: Application to Chondroitin, Chondroitin Sulfate, and Hyaluronic Acid Biophys. J., June 1, 2005; 88(6): 3870 - 3887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kaplan-Albuquerque, Y. E. Bogaert, V. Van Putten, M. C. Weiser-Evans, and R. A. Nemenoff Patterns of Gene Expression Differentially Regulated by Platelet-derived Growth Factor and Hypertrophic Stimuli in Vascular Smooth Muscle Cells: MARKERS FOR PHENOTYPIC MODULATION AND RESPONSE TO INJURY J. Biol. Chem., May 20, 2005; 280(20): 19966 - 19976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Blundell, A. Almond, D. J. Mahoney, P. L. DeAngelis, I. D. Campbell, and A. J. Day Towards a Structure for a TSG-6{middle dot}Hyaluronan Complex by Modeling and NMR Spectroscopy: INSIGHTS INTO OTHER MEMBERS OF THE LINK MODULE SUPERFAMILY J. Biol. Chem., May 6, 2005; 280(18): 18189 - 18201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rahmani, J. T. Read, J. M. Carthy, P. C. McDonald, B. W. Wong, M. Esfandiarei, X. Si, Z. Luo, H. Luo, P. S. Rennie, et al. Regulation of the Versican Promoter by the {beta}-Catenin-T-cell Factor Complex in Vascular Smooth Muscle Cells J. Biol. Chem., April 1, 2005; 280(13): 13019 - 13028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. T. Seyfried, C. D. Blundell, A. J. Day, and A. Almond Preparation and application of biologically active fluorescent hyaluronan oligosaccharides Glycobiology, March 1, 2005; 15(3): 303 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Wight The ADAMTS Proteases, Extracellular Matrix, and Vascular Disease: Waking the Sleeping Giant(s)! Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 12 - 14. [Full Text] [PDF]
|
|